Related Experiment Video
Updated: Nov 24, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
[Anti-atherosclerotic effects of PPAR gamma ligands]
1Department of Emergency Medicine, School of Medicine, Keio University.
Abstract:
Peroxisome proliferator-activated receptor gamma(PPAR gamma) belongs to a nuclear receptor super family which is activated by insulin sensitizer, thiazolidinediones. The expression of PPAR gamma was detected in the vascular tissues and PPAR gamma ligands have various effects on all cells which constitute the vasculature including endothelial cells, vascular smooth muscle cells and monocytes/macrophages. The net effect by PPAR gamma ligands is proven to be anti-atherosclerosis. In various atherosclerogenic mouse models and balloon injury model, PPAR gamma ligands attenuate atherosclerotic lesion formation and intimal hyperplasia. In human study, various beneficial effects by PPAR gamma ligands were reported in terms of atherogenesis. PPAR gamma ligands attenuate the increase in intima-media thickness in diabetic patients. However, long-term effects remain to be seen.
Insights
Peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands show anti-atherosclerosis effects by reducing lesion formation and intimal hyperplasia in studies. These ligands also attenuate intima-media thickness increases in diabetic patients, though long-term impacts require further investigation.
Area of Science:
- Cardiovascular Research
- Endocrinology
- Molecular Biology
Context:
- Peroxisome proliferator-activated receptor gamma (PPAR gamma), a nuclear receptor, is activated by insulin sensitizers like thiazolidinediones.
- PPAR gamma is expressed in vascular tissues, influencing endothelial cells, smooth muscle cells, and macrophages.
- PPAR gamma ligands demonstrate pleiotropic effects on vascular cells.
Purpose:
- To investigate the role and therapeutic potential of PPAR gamma ligands in the context of atherosclerosis.
- To summarize the anti-atherosclerotic effects of PPAR gamma ligands observed in preclinical and clinical studies.
Summary:
- PPAR gamma ligands exhibit significant anti-atherosclerotic properties, attenuating lesion development and intimal hyperplasia in various animal models.
- In human studies, particularly in diabetic patients, PPAR gamma ligands have been shown to reduce intima-media thickness.
- The expression of PPAR gamma in key vascular cell types underscores its importance in vascular homeostasis and disease.
Impact:
- PPAR gamma ligands represent a promising therapeutic strategy for managing and potentially preventing atherosclerosis.
- Further long-term studies are warranted to fully elucidate the sustained benefits and safety profile of PPAR gamma ligands in atherogenesis.
- Understanding PPAR gamma's function in vascular cells opens new avenues for targeted therapies against cardiovascular diseases.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
GPCR Desensitization
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

